Skip to content

Alkermes ALKS Deferred Revenue

Deferred Revenue at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$69.2M-14.7%
Arrowhead Research logo
Arrowhead ResearchARWR
$108.54M+151%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$6.12M-65.1%
ALN
Alnylam PharmaceuticalsALNY
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
Exelixis logo
ExelixisEXEL

Other financials

Income statement

See full
Revenue$392.9M+28.2%
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×
P/S4.8×+0.3×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity9.4%-16.1pp
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: Alkermes’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's deferred revenue?
Alkermes (ALKS) reported deferred revenue of $0 in Q4 2025.
How has Alkermes's deferred revenue changed year-over-year?
Alkermes's deferred revenue decreased by 100.0% year-over-year, from $1.25M to $0.
What is the long-term trend for Alkermes's deferred revenue?
Over 5 years (2020 to 2025), Alkermes's deferred revenue has grown at a -100.0% compound annual growth rate (CAGR), from $7.51M to $0.
What does deferred revenue mean?
Payments received in advance for goods or services not yet provided.
How do you interpret deferred revenue?
An increase is a positive indicator of future revenue growth and strong customer demand, while a decrease suggests revenue recognition is outpacing new bookings.
How does deferred revenue compare across companies?
Common in companies with subscription models or long-term service contracts, including biotech licensing agreements.